Deciduous Therapeutics

About:

Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune modulatory therapies.

Website: https://www.deciduoustx.com/

Top Investors: Global Brain Corporation, 8VC, CRV, Bold Capital Partners, Presight Capital

Description:

Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune-modulatory therapies that clear senescent cells and promote a healthy lifespan. Deciduous is led by Anil Bhushan, a professor at UCSF, and Robin Mansukhani, a five-time biotech founder.

Total Funding Amount:

$16.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2018-01-01

Founders:

Anil Bhushan, Robin Mansukhani

Number of Employees:

11-50

Last Funding Date:

2022-12-31

IPO Status:

Private

Industries:

© 2025 bioDAO.ai